Form 8-K - Current report:
SEC Accession No. 0001213900-21-026172
Filing Date
2021-05-14
Accepted
2021-05-13 17:58:08
Documents
13
Period of Report
2021-05-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea140743-8k_cormedix.htm   iXBRL 8-K 24608
2 PRESS RELEASE DATED MAY 13, 2021 ea140743ex99-1_cormedix.htm EX-99.1 10242
  Complete submission text file 0001213900-21-026172.txt   210829

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crmd-20210513.xsd EX-101.SCH 3023
4 XBRL LABEL FILE crmd-20210513_lab.xml EX-101.LAB 34238
5 XBRL PRESENTATION FILE crmd-20210513_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT ea140743-8k_cormedix_htm.xml XML 3593
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 21921110
SIC: 2834 Pharmaceutical Preparations